8 December 2022

A state-of-the-art, on-demand CME course for clinicians involved with the diagnosis and management of care for patients with facioscapulohumeral muscular dystrophy (FSHD) was made available on demand by the FSHD Society for a fee (50 dollars per person). The course will present information on the latest in diagnosis, genetic counseling and testing, natural history, symptom management, and standards of care. This course will also provide a forum for thought leaders to share ideas, challenges and successes in delivering optimal care to people with FSHD. Those taking the course will learn about the current therapy development and clinical trial landscape and the emerging implications for care.